5.62
+0.17
+(3.09%)
At close: January 24 at 4:00:00 PM EST
5.74
+0.12
+(2.07%)
After hours: January 24 at 4:52:48 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-29,964.00
-36,911.00
-42,932.00
-52,308.00
-38,203.00
Investing Cash Flow
29,515.00
22,330.00
12,384.00
-48,048.00
--
Financing Cash Flow
171.00
2,876.00
507.00
--
187,389.00
End Cash Position
22,678.00
21,465.00
32,786.00
62,563.00
163,836.00
Capital Expenditure
--
--
-196.00
-223.00
--
Issuance of Capital Stock
171.00
2,876.00
507.00
--
192,341.00
Free Cash Flow
-29,964.00
-36,911.00
-43,128.00
-52,531.00
-38,203.00
12/31/2020 - 10/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
1.9700
+1.03%
TBPH Theravance Biopharma, Inc.
10.47
+8.27%
BOLT Bolt Biotherapeutics, Inc.
0.5101
-3.39%
ANTX AN2 Therapeutics, Inc.
1.2500
0.00%
IPSC Century Therapeutics, Inc.
0.9000
-1.11%
ASMB Assembly Biosciences, Inc.
14.77
-0.67%
VTYX Ventyx Biosciences, Inc.
2.2500
-2.60%
KROS Keros Therapeutics, Inc.
11.84
-1.50%
SPRO Spero Therapeutics, Inc.
0.8677
-0.36%
OKUR OnKure Therapeutics, Inc.
5.66
+5.20%